Lexicon earns third $10 million Novo Nordisk milestone payment
Lexicon Pharmaceuticals says it earned a third $10 million milestone payment from Novo Nordisk after achieving a key Phase 1 development milestone for LX9851.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.